Autoren
Dr. John O'Brien
Life/Health Chief Medical Officer, London
Dr. John O'Brien is the Chief Medical Officer (CMO) for Gen Re Life/Health Research and Development, based in the UK. Before joining Gen Re as CMO, he worked as consultant for Gen Re in Cape Town while running a pulmonology practice and clinical trial centre. Dr. O'Brien is a past president of the South African Thoracic Society and served on the editorial committees for the South African Thoracic Society guidelines for asthma and COPD. He has been a clinical investigator in more than 70 clinical trials in asthma and COPD.
-
RPaktuell 2019, Nr. 1
Ausgabe: Jul 15, 2019Deutsch
Das Potenzial von genetischen Untersuchungen verstehen / Genetische Untersuchungen weltweit / Ein aktueller Überblick über erblichen Brustkrebs / Die Bewertung von erblichem Brustkrebs im Underwriting / Warum Risikoprüfer ein Verständnis von Mukoviszidose...
Kunden-Login erforderlich Erfahren Sie mehr -
Underwriting Focus 2019, No. 1
Ausgabe: Jun 11, 2019English
In this edition of Underwriting Focus, we highlight a few of the innovative medical trends that require the insurance industry’s response and discuss how medical progress can be transferred to underwriting guidelines.
Kunden-Login erforderlich Erfahren Sie mehr -
Underwriting Focus 2018, No. 2
Ausgabe: Feb 20, 2019Français
Voici une nouvelle publication sur le thème de la génétique et de ses possibles applications dans le domaine assurantiel.
Kunden-Login erforderlich Erfahren Sie mehr -
Underwriting Focus 2018, No. 2
Ausgabe: Nov 06, 2018English
The article discusses genetic testing, worldwide regulations and advances in personalised medicine. Additionally we look into two specific genetic diseases – breast cancer and cystic fibrosis – and their assessment in underwriting.
Kunden-Login erforderlich Erfahren Sie mehr
Meistgelesen
Themen
Capital Management
Life/Health
Property/Casualty
Autoren
Lernen Sie unsere Experten kennen
